InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
17
T+90 hit rate
11%
T+90 mean return
-28.2%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Shah Pritesh, Directeur Commercial. Director active across 1 company, notably NovoCure Ltd. Aggregated, 26 filings have been recorded. Split: 0 buy · 17 sells. Total volume traded: €10.1m. Activity tracked since 3 May 2021. The latest transaction was filed on 7 November 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations26 total
382 shares@ US$12.650.0% of flowOrdinary SharesSEC:0001562180-23-007594:0
273 shares@ US$21.81720.0% of flowOrdinary SharesSEC:0001562180-23-006680:0
367 shares@ US$35.280.1% of flowOrdinary SharesSEC:0001562180-23-005760:0
1,570 shares@ US$76.15941.0% of flowOrdinary SharesSEC:0001562180-23-002580:0
937 shares@ US$75.27790.6% of flowOrdinary SharesSEC:0001562180-23-002492:0
19,055 shares0Ordinary SharesSEC:0001645113-23-000030:0
387 shares@ US$108.000.3% of flowOrdinary SharesSEC:0001645113-23-000008:0
269 shares@ US$79.0370.2% of flowOrdinary SharesSEC:0001645113-22-000075:0
312 shares@ US$59.0750.2% of flowOrdinary SharesSEC:0001645113-22-000059:0
3,717 shares@ US$154.010.033% mcap4.3% of flowOrdinary SharesSEC:0001645113-22-000031:0
5,294 shares@ US$69.550.023% mcap3.0% of flowOrdinary SharesSEC:0001645113-22-000030:0
21,714 shares0Ordinary SharesSEC:0001645113-22-000020:0
156 shares@ US$138.2320.0012% mcap0.2% of flowOrdinary SharesSEC:0001645113-21-000106:0
156 shares@ US$138.2320.2% of flowOrdinary SharesSEC:0001645113-21-000106
2,063 shares@ US$148.710.018% mcap2.3% of flowOrdinary SharesSEC:0001645113-21-000100:0
2,063 shares@ US$148.712.3% of flowOrdinary SharesSEC:0001645113-21-000100
1,654 shares@ US$149.430.014% mcap1.9% of flowOrdinary SharesSEC:0001645113-21-000097:0
1,654 shares@ US$149.431.8% of flowOrdinary SharesSEC:0001645113-21-000097
154 shares@ US$137.1220.0012% mcap0.2% of flowRestricted Share UnitsSEC:0001645113-21-000083:0
154 shares@ US$137.1220.2% of flowRestricted Share UnitsSEC:0001645113-21-000083
23,540 shares@ US$215.0036.4% of flowOrdinary SharesSEC:0001645113-21-000080
23,540 shares@ US$215.000.29% mcap37.3% of flowOrdinary SharesSEC:0001645113-21-000080:0
1,290 sharesOrdinary SharesSEC:0001645113-21-000065
1,290 shares@ US$199.670.015% mcap1.9% of flowOrdinary SharesSEC:0001645113-21-000065:0
2,333 shares@ US$204.103.5% of flowOrdinary SharesSEC:0001645113-21-000063
25 of 26 declarations
About Shah Pritesh
Shah Pritesh is the Chief Commercial Officer of NovoCure Ltd. He is responsible for the company's sales and marketing strategies.
